Kozak & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64.8K Hold
50
– – 0.01% 125
2026
Q2
$59.9K Hold
50
– – 0.01% 137
2026
Q1
$46.8K Sell
50
-10
-17% -$10.1K 0.01% 154
2025
Q4
$64.1K Hold
60
– – 0.01% 131
2025
Q3
$61.6K Buy
60
+35
+140% +$26K 0.01% 136
2025
Q2
$19.8K Hold
25
– – ﹤0.01% 194
2025
Q1
$19K Hold
25
– – ﹤0.01% 176
2024
Q4
$19.6K Buy
25
+10
+67% +$8.28K ﹤0.01% 182
2024
Q3
$14.1K Hold
15
– – ﹤0.01% 208
2024
Q2
$13.8K Sell
15
-1
-6% -$800 ﹤0.01% 204
2024
Q1
$12.1K Buy
16
+1
+7% +$712 ﹤0.01% 219
2023
Q4
$9.7K Sell
15
-7
-32% -$4.09K ﹤0.01% 237
2023
Q3
$12.6K Buy
22
+15
+214% +$7.73K ﹤0.01% 218
2023
Q2
$3.36K Hold
7
– – ﹤0.01% 285
2023
Q1
$2.49K Hold
7
– – ﹤0.01% 294
2022
Q4
$3K Hold
7
– – ﹤0.01% 290
2022
Q3
$2K Hold
7
– – ﹤0.01% 301
2022
Q2
$2K Hold
7
– – ﹤0.01% 338
2022
Q1
$2K Hold
7
– – ﹤0.01% 351
2021
Q4
$2K Hold
7
– – ﹤0.01% 351
2021
Q3
$2K Buy
+7
New +$1.73K ﹤0.01% 306

Other funds holding LLY

Kozak & Associates's LLY Position: Q3 2026 in Review

Kozak & Associates held its Eli Lilly (LLY) position steady in Q3 2026 at 50 shares worth $64.8K. The position accounts for 0.01% of the portfolio, ranked #125.

Kozak & Associates first reported a position in LLY in Q3 2021 and has held it in 21 quarters since. 4,628 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kozak & Associates held 50 shares of Eli Lilly worth $64.8K as of Q3 2026.
  • Kozak & Associates left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.01% of Kozak & Associates's portfolio in Q3 2026, its #125 holding.
  • Kozak & Associates first reported a position in Eli Lilly in Q3 2021 and has held it in 21 quarters since.
  • 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.